Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
42
Frequently Asked Questions
What is Market Cap of Anavex Life Sciences Corporation?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Anavex Life Sciences Corporation market cap is $803.97M.
What is the 52-week high for Anavex Life Sciences Corporation?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Anavex Life Sciences Corporation 52 week high is $14.44 as of September 05, 2025.
What is the 52-week low for Anavex Life Sciences Corporation?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Anavex Life Sciences Corporation 52 week low is $4.93 as of September 05, 2025.
What is Anavex Life Sciences Corporation stock price today?
Anavex Life Sciences Corporation stock price today is $9.47.
What was Anavex Life Sciences Corporation stock price yesterday?
Anavex Life Sciences Corporation stock price yesterday was $9.36.
What is the PE ratio of Anavex Life Sciences Corporation?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Anavex Life Sciences Corporation’s P/E ratio is -16.52.
What is the Price-to-Book ratio of Anavex Life Sciences Corporation?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Anavex Life Sciences Corporation P/B ratio is 8.7892.
What is the 50-day moving average of Anavex Life Sciences Corporation?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Anavex Life Sciences Corporation 50-day moving average is $10.51.
How many employess does Anavex Life Sciences Corporation has?
Anavex Life Sciences Corporation has 42 employees.